Conventional type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities

.

Source: Expert Opinion on Biological Therapy - October 27, 2021 Category: Drugs & Pharmacology Authors: Phillip Johnson Nikita Rosendahl Kristen J Radford Source Type: research